Brief: Vivos Inc Obtains Feedback From The FDA On Clinical Testing Of Radiogel™
02/12/2021 14:39
Dec 2 (Reuters) - Vivos Inc RDGL.PK :
* VIVOS INC OBTAINS FEEDBACK FROM THE FDA ON CLINICAL
TESTING OF
RADIOGEL™
Source text for Eikon: ID:nGNX1nMHMh
Further company coverage: RDGL.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivos
See all newsBrief: Vivos Inc. Announces Progress Toward FDA Investigational Device Exemption (Ide) Submission
Brief: Vivos Inc. Strengthens Strategic Collaboration With Exubrion Therapeutics
Brief: Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., To Support Ide Submission For Radiogel®
Brief: Vivos Board Authorizes To Establish A Corporate Entity In India
Brief: Vivos Inc. Achieves Record Growth In IsoPet® Animal Cancer Treatments In Q1 2025